Mind over fatigue: new study tests meditation and yoga for blood cancer patients
NCT ID NCT03735992
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a mind-body group program can help reduce fatigue in people who have finished treatment for blood cancers like leukemia or lymphoma. The program includes relaxation, gentle exercise, and stress management techniques. Researchers will compare fatigue levels between those who take the program and those who don't, with 94 participants total.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mind-body group program (based on MBSR and mind-body medicine)
- What this could lead to
- If it works, this could offer a drug-free way to manage fatigue and improve quality of life for blood cancer survivors.
- What could go wrong
- This is a small, early-stage trial with no blinding, so results may be influenced by placebo effects. The program requires significant time commitment and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin
RECRUITINGStuttgart, 70376, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood cancer patients may need higher antibiotic doses to beat superbugs
- New antibody may offer safer shield against transplant complications
- Could a 30-Day habit shift help blood cancer patients regain control?
- Experimental blood cancer drug KK2430 enters first human tests
- New hope for tough blood cancers? early trial launches
- AI translates doctor speak for cancer patients